Thursday, September 10, 2026
The Cancer News
AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER
Katherine Hill, PharmD, BCOP
an Oncology Clinical Pharmacy Specialist
UT Southwestern Medical Center in Dallas, Texas
Published Articles (1)
Recognizing and Treating Triple M Syndrome: A Checkpoint Inhibitor Toxicity Case
July 31, 2026
Triple M syndrome, the co-occurrence of myocarditis, myasthenia gravis, and myositis, is a rare but potentially fatal complication of immune checkpoint inhibitor (ICI) therapy, with reported fatality rates approaching 30-50%.